State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 351 actively recruiting studies with Michigan sites out of 351 registered in total. The busiest research areas in Michigan are Breast Cancer, Ovarian Cancer, Advanced Solid Tumor. Leading sponsors running trials in the state include University of Michigan, National Cancer Institute (NCI), AstraZeneca. By stage, Michigan trials break down as Phase 1 (64), Phase 2 (108), Phase 3 (88), Phase 4 (12).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 351 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 351. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Ovarian Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT06982521 Phase 3
Recruiting
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatme...
Condition
PIK3CA Mutation
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Relay Therapeutics, Inc.
NCT06721962 Phase 1, Phase 2
Recruiting
Treatment of Moderate to Severe Refractory Crohn's Disease
Condition
Crohns Disease
Enrollment
39 pts
Location
United States
Sponsor
Tr1X, Inc.
NCT07244263 Phase 2
Recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Condition
Hidradenitis Suppurativa
Enrollment
90 pts
Location
United States, Australia, Canada
Sponsor
Takeda
NCT04853251 Phase 4
Recruiting
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
188 pts
Location
United States
Sponsor
Genentech, Inc.
NCT05660031 N/A
Recruiting
Treatment of the Biceps With Concomitant Supraspinatus Tears
Condition
Supraspinatus Tear
Enrollment
180 pts
Location
United States, Canada, Switzerland
Sponsor
La Tour Hospital
NCT07094204 Phase 1
Recruiting
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Condition
Solid Tumor
Enrollment
364 pts
Location
United States, France, Japan
Sponsor
Astellas Pharma Inc
NCT06838676 Phase 2
Recruiting
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered ...
Condition
Diffuse Intrinsic Pontine Gliomas (DIPG)
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Nationwide Children's Hospital
NCT06538636 N/A
Recruiting
Prediction Augmented Screening Initiative
Condition
Lung Cancer
Enrollment
23,520 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07054073 N/A
Recruiting
HCMR Re-Imaging Study
Condition
Hypertrophic Cardiomyopathy (HCM)
Enrollment
314 pts
Location
United States, United Kingdom
Sponsor
Christopher Kramer
NCT04101669 N/A
Recruiting
RESET System Pivotal Trial (Rev F)
Condition
Diabetes type2
Enrollment
264 pts
Location
United States
Sponsor
Morphic Medical Inc.
NCT06932081 N/A
Recruiting
Adult Congenital Heart Disease International EValuation of the Effectiveness of ...
Condition
Adult Congenital Heart Disease
Enrollment
400 pts
Location
United States, Germany, Netherlands
Sponsor
Leiden University Medical Cent
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT07215273 Phase 2
Recruiting
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifung...
Condition
Invasive Mould Infection
Enrollment
60 pts
Location
United States, Belgium, Canada
Sponsor
Elion Therapeutics, Inc.
NCT04875429 N/A
Recruiting
Zenith® Fenestrated+ Clinical Study
Condition
Aortic Aneurysm, Abdominal
Enrollment
105 pts
Location
United States, United Kingdom
Sponsor
Cook Research Incorporated
NCT06133972 Phase 3
Recruiting
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participant...
Condition
Systemic Lupus Erythematosus
Enrollment
550 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT05698212 Phase 2
Recruiting
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometrio...
Condition
Endometriosis
Enrollment
75 pts
Location
United States
Sponsor
Hera Biotech, Inc.
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT06517875 Phase 2
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Trans...
Condition
Primary Myelofibrosis
Enrollment
68 pts
Location
United States, Canada, France
Sponsor
GlaxoSmithKline
NCT07089875 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Condition
Gout
Enrollment
500 pts
Location
United States, Poland, Spain
Sponsor
Crystalys Therapeutics
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
NCT07348367 N/A
Recruiting
A Comparison of Radical Prostatectomy and Precision Prostatectomy in Low- and In...
Condition
Prostatectomy
Enrollment
160 pts
Location
United States
Sponsor
Henry Ford Health System
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT06995898 N/A
Recruiting
The Vanguard Study: Testing a New Way to Screen for Cancer
Condition
Bladder Carcinoma
Enrollment
24,000 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06577987 Phase 1
Recruiting
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignanc...
Condition
Advanced Solid Tumor
Enrollment
220 pts
Location
United States
Sponsor
Circle Pharma
NCT06990867 Phase 2, Phase 3
Recruiting
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Condition
Acute Ischemic Stroke
Enrollment
740 pts
Location
United States, Belgium, Bulgaria
Sponsor
Corxel Pharmaceuticals
Page 1 of 15 — 351 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology